Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lobular Carcinoma In Situ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00256217
What this trial is testing

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

Who this might be right for
DCIS
Rita Sanghvi, Mehta 42
Not applicableStudy completedNCT01961531
What this trial is testing

BrUOG 291: Five Fraction Partial Breast Irradiation Using Non-invasive Image-guided Breast Brachytherapy (NIBB)

Who this might be right for
Breast Cancer
Brown University 40
Not applicableStudy completedNCT00749931
What this trial is testing

MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery

Who this might be right for
Breast Cancer
Dune Medical Devices 664
Large-scale testing (Phase 3)Study completedNCT00769379
What this trial is testing

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

Who this might be right for
Breast Ductal Carcinoma In Situ
National Cancer Institute (NCI) 2,014
Large-scale testing (Phase 3)Study completedNCT00026286
What this trial is testing

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

Who this might be right for
Breast CancerHot FlashesMenopausal Symptoms
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT00909909
What this trial is testing

Radiation Therapy in Treating Women With Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Rutgers, The State University of New Jersey 200
Large-scale testing (Phase 3)Looking for participantsNCT01185132
What this trial is testing

Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

Who this might be right for
Breast Cancer
Rocky Mountain Cancer Centers 660
Testing effectiveness (Phase 2)Ended earlyNCT02127073
What this trial is testing

Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Montefiore Medical Center 8
Not applicableStudy completedNCT04365114
What this trial is testing

Patient Outcomes from Second Film-readers and Test Threshold Relaxation in Breast Screening

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
University of Warwick 13,094,122
Early research (Phase 1)Study completedNCT00005886
What this trial is testing

Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
University of Kansas Medical Center
Not applicableStudy completedNCT00602628
What this trial is testing

Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 60
Not applicableStudy completedNCT02766881
What this trial is testing

Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS

Who this might be right for
DCIS
Ontario Clinical Oncology Group (OCOG) 281
Large-scale testing (Phase 3)Active Not RecruitingNCT01272037
What this trial is testing

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaMulticentric Breast Carcinoma+2 more
National Cancer Institute (NCI) 5,018
Testing effectiveness (Phase 2)Study completedNCT00290745
What this trial is testing

Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
University of California, San Francisco 79
Early research (Phase 1)Study completedNCT00788112
What this trial is testing

Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast

Who this might be right for
Breast Cancer
University of California, San Francisco 17
Testing effectiveness (Phase 2)Ended earlyNCT00082667
What this trial is testing

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 1
Not applicableLooking for participantsNCT05912569
What this trial is testing

Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS

Who this might be right for
DCIS
Seoul National University Hospital 84
Not applicableLooking for participantsNCT06350500
What this trial is testing

A Patient Navigation Program for Addressing Disparities in Breast Cancer Care

Who this might be right for
Breast CarcinomaBreast Ductal Carcinoma in Situ
Roswell Park Cancer Institute 126
Not applicableStudy completedNCT00945061
What this trial is testing

Radiation Therapy in Treating Patients With Recurrent Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 13
Large-scale testing (Phase 3)Study completedNCT02961790
What this trial is testing

Oxybutynin Chloride in Managing Hot Flashes

Who this might be right for
Breast CarcinomaDuctal Breast Carcinoma In SituHot Flashes+2 more
Academic and Community Cancer Research United 150
Next Page